ID CP240_MOUSE Reviewed; 491 AA. AC P56657; B2RTP3; DT 15-JUL-1999, integrated into UniProtKB/Swiss-Prot. DT 27-JUL-2011, sequence version 2. DT 27-MAR-2024, entry version 157. DE RecName: Full=Cytochrome P450 2C40; DE EC=1.14.14.- {ECO:0000269|PubMed:10908295}; DE AltName: Full=CYPIIC40; DE Flags: Precursor; GN Name=Cyp2c40 {ECO:0000303|PubMed:9721182, GN ECO:0000312|MGI:MGI:1306815}; OS Mus musculus (Mouse). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae; OC Murinae; Mus; Mus. OX NCBI_TaxID=10090; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA], TISSUE SPECIFICITY, AND FUNCTION. RC STRAIN=CD-1; RX PubMed=9721182; DOI=10.1006/abbi.1998.0806; RA Luo G., Zeldin D.C., Blaisdell J.A., Hodgson E., Goldstein J.A.; RT "Cloning and expression of murine CYP2Cs and their ability to metabolize RT arachidonic acid."; RL Arch. Biochem. Biophys. 357:45-57(1998). RN [2] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. RC TISSUE=Brain; RX PubMed=15489334; DOI=10.1101/gr.2596504; RG The MGC Project Team; RT "The status, quality, and expansion of the NIH full-length cDNA project: RT the Mammalian Gene Collection (MGC)."; RL Genome Res. 14:2121-2127(2004). RN [3] RP FUNCTION, CATALYTIC ACTIVITY, TISSUE SPECIFICITY, AND PATHWAY. RX PubMed=10908295; DOI=10.1124/mol.58.2.279; RA Tsao C.C., Foley J., Coulter S.J., Maronpot R., Zeldin D.C., RA Goldstein J.A.; RT "CYP2C40, a unique arachidonic acid 16-hydroxylase, is the major CYP2C in RT murine intestinal tract."; RL Mol. Pharmacol. 58:279-287(2000). RN [4] RP IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RC TISSUE=Liver; RX PubMed=21183079; DOI=10.1016/j.cell.2010.12.001; RA Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R., RA Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.; RT "A tissue-specific atlas of mouse protein phosphorylation and expression."; RL Cell 143:1174-1189(2010). CC -!- FUNCTION: A cytochrome P450 monooxygenase that may play a major role in CC the metabolism of arachidonic acid in the intestinal tract CC (PubMed:10908295, PubMed:9721182). Exhibits regioselective hydroxylase CC and epoxidase activity toward arachidonic acid, producing 16(R)- CC hydroxyeicosatetraenoic acid (HETE) and (14R,15S)-epoxyeicosatrienoic CC acid (EpETrE) as major products (PubMed:10908295). Mechanistically, CC uses molecular oxygen inserting one oxygen atom into a substrate, and CC reducing the second into a water molecule, with two electrons provided CC by NADPH via cytochrome P450 reductase (CPR; NADPH-ferrihemoprotein CC reductase) (PubMed:10908295). {ECO:0000269|PubMed:10908295, CC ECO:0000269|PubMed:9721182}. CC -!- CATALYTIC ACTIVITY: CC Reaction=(5Z,8Z,11Z,14Z)-eicosatetraenoate + O2 + reduced CC [NADPH--hemoprotein reductase] = 16(R)-hydroxy-(5Z,8Z,11Z,14Z)- CC eicosatetraenoate + H(+) + H2O + oxidized [NADPH--hemoprotein CC reductase]; Xref=Rhea:RHEA:53308, Rhea:RHEA-COMP:11964, Rhea:RHEA- CC COMP:11965, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:15379, CC ChEBI:CHEBI:32395, ChEBI:CHEBI:57618, ChEBI:CHEBI:58210, CC ChEBI:CHEBI:137166; Evidence={ECO:0000269|PubMed:10908295}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:53309; CC Evidence={ECO:0000305|PubMed:10908295}; CC -!- CATALYTIC ACTIVITY: CC Reaction=(5Z,8Z,11Z,14Z)-eicosatetraenoate + O2 + reduced CC [NADPH--hemoprotein reductase] = 16(S)-hydroxy-(5Z,8Z,11Z,14Z)- CC eicosatetraenoate + H(+) + H2O + oxidized [NADPH--hemoprotein CC reductase]; Xref=Rhea:RHEA:53312, Rhea:RHEA-COMP:11964, Rhea:RHEA- CC COMP:11965, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:15379, CC ChEBI:CHEBI:32395, ChEBI:CHEBI:57618, ChEBI:CHEBI:58210, CC ChEBI:CHEBI:137167; Evidence={ECO:0000269|PubMed:10908295}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:53313; CC Evidence={ECO:0000305|PubMed:10908295}; CC -!- CATALYTIC ACTIVITY: CC Reaction=(5Z,8Z,11Z,14Z)-eicosatetraenoate + O2 + reduced CC [NADPH--hemoprotein reductase] = (14R,15S)-epoxy-(5Z,8Z,11Z)- CC eicosatrienoate + H(+) + H2O + oxidized [NADPH--hemoprotein CC reductase]; Xref=Rhea:RHEA:49860, Rhea:RHEA-COMP:11964, Rhea:RHEA- CC COMP:11965, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:15379, CC ChEBI:CHEBI:32395, ChEBI:CHEBI:57618, ChEBI:CHEBI:58210, CC ChEBI:CHEBI:131965; Evidence={ECO:0000269|PubMed:10908295}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:49861; CC Evidence={ECO:0000305|PubMed:10908295}; CC -!- CATALYTIC ACTIVITY: CC Reaction=(5Z,8Z,11Z,14Z)-eicosatetraenoate + O2 + reduced CC [NADPH--hemoprotein reductase] = (14S,15R)-epoxy-(5Z,8Z,11Z)- CC eicosatrienoate + H(+) + H2O + oxidized [NADPH--hemoprotein CC reductase]; Xref=Rhea:RHEA:49856, Rhea:RHEA-COMP:11964, Rhea:RHEA- CC COMP:11965, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:15379, CC ChEBI:CHEBI:32395, ChEBI:CHEBI:57618, ChEBI:CHEBI:58210, CC ChEBI:CHEBI:131964; Evidence={ECO:0000269|PubMed:10908295}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:49857; CC Evidence={ECO:0000305|PubMed:10908295}; CC -!- COFACTOR: CC Name=heme; Xref=ChEBI:CHEBI:30413; CC Evidence={ECO:0000250|UniProtKB:P08684}; CC -!- PATHWAY: Lipid metabolism; arachidonate metabolism. CC {ECO:0000305|PubMed:10908295}. CC -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane; Peripheral CC membrane protein. Microsome membrane; Peripheral membrane protein. CC -!- TISSUE SPECIFICITY: Liver, brain, kidney, and intestine, with trace CC amounts in lung and heart (PubMed:9721182, PubMed:10908295). Expressed CC throughout the intestinal tract, with higher expression levels in CC jejunum, cecum and colon (PubMed:10908295). CC {ECO:0000269|PubMed:10908295, ECO:0000269|PubMed:9721182}. CC -!- SIMILARITY: Belongs to the cytochrome P450 family. {ECO:0000305}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; AF047727; AAD13722.1; -; mRNA. DR EMBL; BC139471; AAI39472.1; -; mRNA. DR EMBL; BC139472; AAI39473.1; -; mRNA. DR CCDS; CCDS29798.3; -. DR RefSeq; NP_034134.2; NM_010004.2. DR AlphaFoldDB; P56657; -. DR SMR; P56657; -. DR BioGRID; 199019; 1. DR STRING; 10090.ENSMUSP00000158887; -. DR SwissLipids; SLP:000001672; -. DR iPTMnet; P56657; -. DR PhosphoSitePlus; P56657; -. DR SwissPalm; P56657; -. DR jPOST; P56657; -. DR MaxQB; P56657; -. DR PaxDb; 10090-ENSMUSP00000125217; -. DR ProteomicsDB; 284108; -. DR Ensembl; ENSMUST00000160476.9; ENSMUSP00000125217.3; ENSMUSG00000025004.17. DR GeneID; 13099; -. DR KEGG; mmu:13099; -. DR AGR; MGI:1306815; -. DR CTD; 13099; -. DR MGI; MGI:1306815; Cyp2c40. DR VEuPathDB; HostDB:ENSMUSG00000025004; -. DR eggNOG; KOG0156; Eukaryota. DR GeneTree; ENSGT00940000155736; -. DR InParanoid; P56657; -. DR OMA; VRSINHH; -. DR OrthoDB; 2900138at2759; -. DR UniPathway; UPA00383; -. DR BioGRID-ORCS; 13099; 2 hits in 48 CRISPR screens. DR PRO; PR:P56657; -. DR Proteomes; UP000000589; Chromosome 19. DR RNAct; P56657; Protein. DR Bgee; ENSMUSG00000025004; Expressed in liver and 16 other cell types or tissues. DR ExpressionAtlas; P56657; baseline and differential. DR GO; GO:0005737; C:cytoplasm; IBA:GO_Central. DR GO; GO:0005789; C:endoplasmic reticulum membrane; IEA:UniProtKB-SubCell. DR GO; GO:0043231; C:intracellular membrane-bounded organelle; IBA:GO_Central. DR GO; GO:0008404; F:arachidonic acid 14,15-epoxygenase activity; IDA:UniProtKB. DR GO; GO:0008392; F:arachidonic acid epoxygenase activity; IBA:GO_Central. DR GO; GO:0020037; F:heme binding; IBA:GO_Central. DR GO; GO:0005506; F:iron ion binding; IEA:InterPro. DR GO; GO:0016712; F:oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen; IBA:GO_Central. DR GO; GO:0019373; P:epoxygenase P450 pathway; IBA:GO_Central. DR GO; GO:0006805; P:xenobiotic metabolic process; IBA:GO_Central. DR CDD; cd20665; CYP2C-like; 1. DR Gene3D; 1.10.630.10; Cytochrome P450; 1. DR InterPro; IPR001128; Cyt_P450. DR InterPro; IPR017972; Cyt_P450_CS. DR InterPro; IPR002401; Cyt_P450_E_grp-I. DR InterPro; IPR036396; Cyt_P450_sf. DR PANTHER; PTHR24300:SF140; CYTOCHROME P450 2C40-RELATED; 1. DR PANTHER; PTHR24300; CYTOCHROME P450 508A4-RELATED; 1. DR Pfam; PF00067; p450; 1. DR PRINTS; PR00463; EP450I. DR PRINTS; PR00385; P450. DR SUPFAM; SSF48264; Cytochrome P450; 1. DR PROSITE; PS00086; CYTOCHROME_P450; 1. PE 1: Evidence at protein level; KW Endoplasmic reticulum; Heme; Iron; Lipid metabolism; Membrane; KW Metal-binding; Microsome; Monooxygenase; Oxidoreductase; KW Reference proteome; Signal. FT SIGNAL 1..25 FT /evidence="ECO:0000255" FT CHAIN 26..491 FT /note="Cytochrome P450 2C40" FT /evidence="ECO:0000255" FT /id="PRO_0000051723" FT BINDING 435 FT /ligand="heme" FT /ligand_id="ChEBI:CHEBI:30413" FT /ligand_part="Fe" FT /ligand_part_id="ChEBI:CHEBI:18248" FT /note="axial binding residue" FT /evidence="ECO:0000250|UniProtKB:P08684" FT CONFLICT 382 FT /note="P -> L (in Ref. 1; AAD13722)" FT /evidence="ECO:0000305" SQ SEQUENCE 491 AA; 55763 MW; 2F4CCEC2F219EA4F CRC64; MDPFVVLVLC LSFLLVLSLW RQRSARGNLP PGPTPLPIIG NYHLIDMKDI GQCLTNFSKT YGPVFTLYFG SQPIVVLHGY EAIKEALIDH GEEFSGRGRI PVFDKVSTGK GIGFSHGNVW KATRVFTVNT LRNLGMGKRT IENKVQEEAQ WLMKELKKTN GSPCDPQFII GCAPCNVICS IVFQNRFDYK DKDFLSLIGK VNECTEILSS PGCQIFNAVP ILIDYCPGSH NKLFKNHTWI KSYLLGKIKE HEESLDVTNP RDFIDYFLIQ RRQKNGIEHM DYTIEHLATL VTDLVFGGTE TLSSTMRFAL LLLMKHTHIT AKVQEEIDNV IGRHRSPCMQ DRNHMPYTNA MVHEVQRYID LGPNGVVHEV TCDTKFRNYF IPKGTQVMTS LTSVLHDSTE FPNPEVFDPG HFLDDNGNFK KSDYFVPFSA GKRICVGESL ARMELFLFLT TILQNFKLKP LVDPKDIDMT PKHSGFSKIP PNFQMCFIPV E //